<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>1Cell.Ai Q1 2025 Newsletter</title>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <style>
    body {
      font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
      background: #f4f7fa;
      color: #333;
      margin: 0;
      padding: 20px;
    }

    .newsletter {
      max-width: 960px;
      margin: auto;
      background: white;
      padding: 40px;
      border-radius: 12px;
      box-shadow: 0 4px 20px rgba(0, 0, 0, 0.1);
    }

    h1,
    h2 {
      color: #003366;
    }

    h1 {
      font-size: 2em;
      margin-bottom: 0;
    }

    h2 {
      margin-top: 40px;
      border-bottom: 2px solid #dfe4ea;
      padding-bottom: 5px;
    }

    ul {
      padding-left: 20px;
    }

    footer {
      text-align: center;
      margin-top: 40px;
      font-size: 0.9em;
      color: #777;
    }

    .highlight {
      background: #e6f2ff;
      padding: 10px;
      border-left: 4px solid #007acc;
      margin: 20px 0;
    }

    .infographic {
      display: flex;
      flex-wrap: wrap;
      justify-content: space-between;
      margin: 30px 0;
    }

    .stat {
      flex: 1 1 200px;
      background: #f0f8ff;
      border-radius: 10px;
      padding: 20px;
      margin: 10px;
      text-align: center;
      box-shadow: 0 2px 6px rgba(0, 0, 0, 0.05);
    }

    .stat-icon {
      font-size: 40px;
      margin-bottom: 10px;
      color: #007acc;
    }

    .stat h3 {
      margin: 10px 0 5px;
      font-size: 1.4em;
      color: #003366;
    }

    .stat p {
      margin: 0;
      font-size: 1.1em;
    }
  </style>
</head>

<body>
  <div class="newsletter">
    <img src="https://nandiraju.github.io/onecell_interns/logo.svg" width="200">
    <div style="text-align: center;">
      <h1>Q1 2025 Newsletter</h1>
      <p><strong>Transforming Precision Oncology – One Cell at a Time</strong></p>
    </div>

    <div class="infographic">
      <div class="stat">
        <div class="stat-icon"><i class="fas fa-dollar-sign"></i></div>
        <h3>$850K</h3>
        <p>India Revenue (Q1)</p>
      </div>
      <div class="stat">
        <div class="stat-icon"><i class="fas fa-globe-americas"></i></div>
        <h3>$85K</h3>
        <p>US Revenue (Q1)</p>
      </div>
      <div class="stat">
        <div class="stat-icon"><i class="fas fa-vial"></i></div>
        <h3>12+</h3>
        <p>Active Clinical Studies</p>
      </div>
      <div class="stat">
        <div class="stat-icon"><i class="fas fa-user-md"></i></div>
        <h3>180/mo</h3>
        <p>Prescribers in India</p>
      </div>
    </div>

    <h2><i class="fas fa-flag"></i> Executive Overview</h2>
    <ul>
      <li>Biopharma Partnerships: Boundless Bio, Xencor</li>
      <li>Series B fundraising in progress</li>
    </ul>

    <h2><i class="fas fa-briefcase"></i> US Business Highlights</h2>
    <p>Targeting $1.6M revenue by year-end with 140+ well-funded biotechs in the ADC/Bispecific space.</p>

    <h2><i class="fas fa-bullhorn"></i> Marketing Momentum</h2>
    <ul>
      <li>New brand identity and US website launched</li>
      <li>Participated in PMWC and AACR</li>
      <li>PR and digital agencies onboarded</li>
    </ul>

    <h2><i class="fas fa-microscope"></i> Clinical Development</h2>
    <p>12+ active studies using OncoRadar™ across NSCLC, breast, pancreatic, and bladder cancers.</p>
    <div class="highlight">
      <strong>ASCO 2025:</strong> Abstract accepted <br />
      <strong>AACR 2025:</strong> Poster on sCTC Platform
    </div>

    <h2><i class="fas fa-microchip"></i> Scientific & Software Innovation</h2>
    <ul>
      <li><strong>iLIMS:</strong> Sample & logistics tracking</li>
      <li><strong>iCare:</strong> RNA & methylation support</li>
      <li><strong>Dr. G App:</strong> AI assistant for oncologists</li>
    </ul>

    <h2><i class="fas fa-user-nurse"></i> India Business Update</h2>
    <ul>
      <li>30+ hospital MOUs signed</li>
      <li>Strategic expansion: Turkey, Malaysia, Egypt, CIS countries</li>
      <li>New Customer Experience department launched</li>
    </ul>

    <h2><i class="fas fa-flask"></i> Lab Operations & Automation</h2>
    <p>New CLIA-certified lab in Foster City is operational. CAP certification in progress.</p>

    <h2><i class="fas fa-rocket"></i> Product Portfolio Expansion</h2>
    <p><strong>Launched:</strong> OncoIndx Prime v2.0, OncoMonitor® MRD, OncoHRD, OncoPredikt BS</p>
    <p><strong>Coming Soon:</strong> OncoHeme, OncoNeuro, OncoPredikt HRD & BRS</p>

    <h2><i class="fas fa-certificate"></i> R&D & Regulatory</h2>
    <ul>
      <li>sCTC Validation: 1,368 patients</li>
      <li>5 New Patent Filings</li>
      <li>NABL Accredited; CAP/CLIA in progress</li>
    </ul>

    <h2><i class="fas fa-handshake"></i> Strategic Partnerships</h2>
    <p>Collaborations with BioSkryb for single-cell multiomics and iCRO setup in India.</p>

    <h2><i class="fas fa-vials"></i> ADC Market Readiness</h2>
    <p>CTC-based biomarkers (HER2, Trop2) now accessible for ADC therapy decision-making.</p>

    <h2><i class="fas fa-newspaper"></i> Publications & IP</h2>
    <p>15+ abstracts accepted, published in top oncology journals. Tech highlighted at AACR.</p>

    <h2><i class="fas fa-tags"></i> Trademarks</h2>
    <ul>
      <li>OncoIndx</li>
      <li>OncoMonitor</li>
      <li>OncoPredikt</li>
      <li>CellBiopsy</li>
      <li>OneCell Solo</li>
    </ul>

    <h2><i class="fas fa-compass"></i> Looking Ahead</h2>
    <ul>
      <li>Launch CEPO Sites</li>
      <li>Expand automation with OneCell Solo</li>
      <li>New launches in hematology & neuro-oncology</li>
    </ul>

    <footer>
      © 2025 1Cell.Ai. All rights reserved.
    </footer>
  </div>
</body>

</html>